What To Know: Early Monday, IonQ revealed a major European expansion, deploying Slovakia's first national quantum ...
Lead product GelrinC®, a hydrogel synchronized erosion and resorbable implant, the only restorative product for knee ...
Founded in 2009, Tides has evolved from a distributor of birth-tissue products into a biotechnology platform focused on ...
São Paulo continues its internal restructuring process for the 2026 season, following a terrible year, especially in its ...
The Global Bio Preservation Market presents growth opportunities driven by the rising demand for organ transplants and ...
The NCAA must still formally approve the rule change, but it is expected to pass, with a dealmaking frenzy to follow.
With IonQ bringing quantum computing into healthcare, is now the time for investors to start paying attention to this stock?
São Paulo continues its internal restructuring process for the 2026 season, after a terrible year, especially in its health ...
March Bio is continuing enrollment in the Phase 2 trial, with the Independent Data Monitoring Committee’s approval to advance to Simon Stage 2 of the Phase 2 trial. The Company anticipates presenting ...
Healogics Wound Care Supply adds UltraMIST to its Group Purchasing OrganizationHealogics iSupply and Sanuwave collaborate to provide UltraMIST as ...
TipRanks on MSN
Immix Biopharma announces positive phase 2 trial results
The latest announcement is out from Immix Biopharma ( (IMMX) ).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results